0020

Shanghai Kehua Bio-Engineering Co.,Ltd (002022)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
6. 67
+0.06
+0.91%
¥
3.55B Market Cap
- P/E Ratio
2.4% Div Yield
5,037,447 Volume
- Eps
¥ 6.61
Previous Close
Day Range
6.59 6.71
Year Range
5.05 11.85
Want to track 002022 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002022 Chart

Shanghai Kehua Bio-Engineering Co.,Ltd Profile

Medical Devices Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE000001KC9 ISIN
China Country
2,151 Employees
- Last Dividend
27 May 2010 Last Split
- IPO Date

Overview

Shanghai Kehua Bio-Engineering Co.,Ltd, established in 1981 and based in Shanghai, the People's Republic of China, operates within the biotechnological industry focusing on the research, development, production, and sales of in vitro diagnostic reagents and medical testing equipment both domestically and internationally. The company's extensive product portfolio caters to a variety of medical and research needs, supporting hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. Additionally, Shanghai Kehua Bio-Engineering Co.,Ltd has an international presence, exporting its products to global markets.

Products and Services

  • Immunoassay & Clinical Chemistry Systems: These are used for performing various biochemical analyses, essential in diagnosing conditions and monitoring patient health.
  • HIV Colloid Gold Test Kits: A rapid testing tool for the detection of HIV infection, based on the gold colloid method, enabling quick diagnosis and intervention.
  • ELISA HBV Test Kits: These kits employ the Enzyme-Linked Immunosorbent Assay (ELISA) technique for the detection of Hepatitis B virus, facilitating early diagnosis and management of the infection.
  • Renal Disease Management: Providing solutions aimed at diagnosing, monitoring, and managing renal diseases, aiding in early detection and preventing disease progression.
  • Automated Comprehensive Solutions for Nucleic Acid Blood Screening: Advanced systems for screening blood samples for nucleic acids, enhancing the safety and quality of blood transfusions.
  • Automatic Modular and Clinical Chemistry Analyzer: Equipments designed for automating the process of clinical chemistry analysis, increasing efficiency and accuracy in laboratories.
  • Automatic Chemiluminescence Immunoassay Analyzers: These analyzers use chemiluminescence methodology for conducting immunoassays, offering sensitive, fast, and high-throughput options for diagnostic testing.
  • CLIA Reagents Tests: Reagents specifically designed for use in chemiluminescence immunoassays, supporting the detection of various biomarkers.
  • Automatic Microplate Reader and Microplate Washer: Instruments that automate the reading and washing of microplates used in ELISA testing, streamline laboratory workflows.
  • Enzyme-linked Immunoassay Reagents: A broad range of reagents for use in ELISA tests, enabling the detection and quantification of antigens or antibodies in samples.
  • Diagnostic Kit for HIV and SARS-CoV-2 IgM/IgG Antibody: A diagnostic solution for rapidly identifying the presence of antibodies against HIV and SARS-CoV-2, aiding in the management of these infections.
  • Fully Automated Nucleic Acid Blood Screening Laboratory and Molecular Diagnostics Solutions: Comprehensive solutions that automate the process of nucleic acid testing and molecular diagnostics, facilitating accurate and efficient disease diagnosis and management.

Contact Information

Address: Caohejing Hi-Tech Park
Phone: 86 21 6495 0625